Livingston Group Asset Management CO operating as Southport Capital Management continued to hold its stake in Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The firm owned 2,100 shares of the insurance provider’s stock at the end of the second quarter. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in Humana were worth $378,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Advisor Partners LLC raised its stake in Humana by 9.3% in the first quarter. Advisor Partners LLC now owns 2,211 shares of the insurance provider’s stock worth $405,000 after buying an additional 188 shares during the last quarter. Bessemer Group Inc. raised its stake in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares during the last quarter. NN Investment Partners Holdings N.V. purchased a new stake in shares of Humana during the first quarter worth about $3,104,000. Columbia Partners L L C Investment Management raised its stake in shares of Humana by 6.5% in the first quarter. Columbia Partners L L C Investment Management now owns 10,476 shares of the insurance provider’s stock worth $1,916,000 after buying an additional 638 shares in the last quarter. Finally, Howard Hughes Medical Institute raised its stake in shares of Humana by 67.3% in the first quarter. Howard Hughes Medical Institute now owns 8,380 shares of the insurance provider’s stock worth $1,533,000 after buying an additional 3,372 shares in the last quarter. 93.24% of the stock is owned by institutional investors and hedge funds.
Shares of Humana Inc. (NYSE:HUM) traded up 0.61% during mid-day trading on Friday, reaching $176.89. 825,764 shares of the company traded hands. The firm’s 50 day moving average price is $177.23 and its 200-day moving average price is $176.36. The company has a market capitalization of $26.37 billion, a P/E ratio of 27.18 and a beta of 0.91. Humana Inc. has a 52-week low of $150.00 and a 52-week high of $191.65.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. The firm earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The firm’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.67 EPS. Equities analysts predict that Humana Inc. will post $9.26 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is 18.18%.
A number of brokerages recently issued reports on HUM. Argus reissued a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. JPMorgan Chase & Co. lowered shares of Humana from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $196.00 to $150.00 in a report on Friday, July 8th. RBC Capital Markets reissued a “buy” rating and issued a $224.00 price objective (up previously from $220.00) on shares of Humana in a report on Friday, July 22nd. Jefferies Group raised shares of Humana from a “hold” rating to a “buy” rating and upped their price objective for the company from $158.89 to $210.00 in a report on Monday, July 18th. Finally, Wolfe Research began coverage on shares of Humana in a report on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $200.93.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.